Globus Medical (GMED)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 5,251,750 5,086,040 4,993,790 4,943,610 5,086,080 5,355,880 2,212,460 2,149,620 2,076,130 1,976,510 1,914,710 1,998,690 1,957,260 1,910,580 1,830,210 1,737,890 1,679,480 1,541,740 1,465,800 1,479,360
Total stockholders’ equity US$ in thousands 4,177,330 4,069,400 3,976,360 3,922,360 3,997,960 4,187,280 1,985,060 1,914,820 1,846,370 1,764,110 1,699,090 1,785,370 1,741,390 1,718,270 1,639,270 1,562,990 1,506,300 1,417,200 1,336,920 1,363,370
Financial leverage ratio 1.26 1.25 1.26 1.26 1.27 1.28 1.11 1.12 1.12 1.12 1.13 1.12 1.12 1.11 1.12 1.11 1.11 1.09 1.10 1.09

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $5,251,750K ÷ $4,177,330K
= 1.26

The financial leverage ratio of Globus Medical has shown a gradual increase over the years, reflecting a slight upward trend in the company's leverage position. The ratio has consistently remained above 1, indicating that the company has more debt in its capital structure compared to equity.

From March 31, 2020, to December 31, 2024, the financial leverage ratio has varied between 1.09 and 1.28. However, the quarterly fluctuations are relatively minor, with only a marginal increase seen in recent quarters. The ratio peaked at 1.28 on September 30, 2023, before slightly decreasing in the following periods.

Overall, the financial leverage ratio suggests that Globus Medical has been relying more on debt financing to fund its operations and growth activities. Investors and stakeholders typically use this ratio to assess the company's risk level and its ability to meet financial obligations. It is important for the company to carefully manage its debt levels to maintain a healthy balance between debt and equity in its capital structure.